Cost containment and managed care: Evidence from German macro data

Research output: Working paperWorking papers

Standard

Cost containment and managed care: Evidence from German macro data. / Ehlert, Andree; Oberschachtsiek, Dirk; Prawda, Stefan.
Lüneburg: Institut für Volkswirtschaftslehre der Universität Lüneburg, 2013. (Working Paper Series in Economics; No. 284).

Research output: Working paperWorking papers

Harvard

Ehlert, A, Oberschachtsiek, D & Prawda, S 2013 'Cost containment and managed care: Evidence from German macro data' Working Paper Series in Economics, no. 284, Institut für Volkswirtschaftslehre der Universität Lüneburg, Lüneburg.

APA

Ehlert, A., Oberschachtsiek, D., & Prawda, S. (2013). Cost containment and managed care: Evidence from German macro data. (Working Paper Series in Economics; No. 284). Institut für Volkswirtschaftslehre der Universität Lüneburg.

Vancouver

Ehlert A, Oberschachtsiek D, Prawda S. Cost containment and managed care: Evidence from German macro data. Lüneburg: Institut für Volkswirtschaftslehre der Universität Lüneburg. 2013 Oct. (Working Paper Series in Economics; 284).

Bibtex

@techreport{3b78631abd2e4dd58fc9b1343fa641c4,
title = "Cost containment and managed care: Evidence from German macro data",
abstract = "The major German health care reforms undertaken since the late 1990s resulted in the adoption of selective contracting mechanisms in a formerly sectorally separated health care system. These reforms marked the launch of managed care in Germany that is expected to yield both a higher quality of care and cost containment. We investigate if managed care had an in fluence on the structure of health care expenditure in Germany during the start-up phase of managed care from 2004 to 2008. We focus on pharmaceutical spending by statutory sickness funds (i.e. German law- enforced health insurance). We followed a macroeconomic evaluation approach based on a regional panel data set in contrast to previous research and were thus able to control for a comprehensive set of regional and demographic variables. We discuss alternative model specifications and include a range of sensitivity analyses. Our results suggest that in contrast to public perception the share of managed care contracts has a positive impact on pharmaceutical spending.",
keywords = "Economics, managed care, health care expenditure, pharmaceutical expenditure, panel data, german health care reform",
author = "Andree Ehlert and Dirk Oberschachtsiek and Stefan Prawda",
year = "2013",
month = oct,
language = "English",
series = "Working Paper Series in Economics",
publisher = "Institut f{\"u}r Volkswirtschaftslehre der Universit{\"a}t L{\"u}neburg",
number = "284",
type = "WorkingPaper",
institution = "Institut f{\"u}r Volkswirtschaftslehre der Universit{\"a}t L{\"u}neburg",

}

RIS

TY - UNPB

T1 - Cost containment and managed care: Evidence from German macro data

AU - Ehlert, Andree

AU - Oberschachtsiek, Dirk

AU - Prawda, Stefan

PY - 2013/10

Y1 - 2013/10

N2 - The major German health care reforms undertaken since the late 1990s resulted in the adoption of selective contracting mechanisms in a formerly sectorally separated health care system. These reforms marked the launch of managed care in Germany that is expected to yield both a higher quality of care and cost containment. We investigate if managed care had an in fluence on the structure of health care expenditure in Germany during the start-up phase of managed care from 2004 to 2008. We focus on pharmaceutical spending by statutory sickness funds (i.e. German law- enforced health insurance). We followed a macroeconomic evaluation approach based on a regional panel data set in contrast to previous research and were thus able to control for a comprehensive set of regional and demographic variables. We discuss alternative model specifications and include a range of sensitivity analyses. Our results suggest that in contrast to public perception the share of managed care contracts has a positive impact on pharmaceutical spending.

AB - The major German health care reforms undertaken since the late 1990s resulted in the adoption of selective contracting mechanisms in a formerly sectorally separated health care system. These reforms marked the launch of managed care in Germany that is expected to yield both a higher quality of care and cost containment. We investigate if managed care had an in fluence on the structure of health care expenditure in Germany during the start-up phase of managed care from 2004 to 2008. We focus on pharmaceutical spending by statutory sickness funds (i.e. German law- enforced health insurance). We followed a macroeconomic evaluation approach based on a regional panel data set in contrast to previous research and were thus able to control for a comprehensive set of regional and demographic variables. We discuss alternative model specifications and include a range of sensitivity analyses. Our results suggest that in contrast to public perception the share of managed care contracts has a positive impact on pharmaceutical spending.

KW - Economics

KW - managed care

KW - health care expenditure

KW - pharmaceutical expenditure

KW - panel data

KW - german health care reform

M3 - Working papers

T3 - Working Paper Series in Economics

BT - Cost containment and managed care: Evidence from German macro data

PB - Institut für Volkswirtschaftslehre der Universität Lüneburg

CY - Lüneburg

ER -

Documents